Test Overview
Test Methodology

ctDNA Detection

Test Usage

Signatera™ is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment, treatment response monitoring, and early recurrence monitoring.

Reference Range *

Interpretive report provided

* Reference ranges may change over time. Please refer to the original patient report when evaluating results.

Test Details
Days Set Up
Monday - Friday
Analytic Time

7 - 10 days

Soft Order Code
NSGN2
Synonyms
    Laboratory
    Sendout
    Reference Laboratory
    Natera
    Section
    Special Testing
    Specimen Requirements
    Collection Instructions

    Collect specimen in Streck tubes in the kit, provided to the patient by the clinic for their arrival in blood draw. Send the entire kit to Specimen Processing ambient (including the test requisition and the shipping airbill in the kit)

    Normal Volume
    20 mL whole blood
    Minimum Volume
    10 mL whole blood
    Storage Temperature
    Ambient
    Additional Information

    Test performed by Natera Laboratories

    Billing
    NY State Approved
    No